Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:34:43.791Z.
Calculation as of: 2026-10-06T21:34:43.791Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49ccfc7bc81d1e6c211e00ba0f17dd71ad394db50a55f8cf6fe3d6b4e4d88636
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Zenas BioPharma, Inc.
Market Cap
$1.70B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Operating Cash Flow Yield
18.69%
TTM Avg
11.27%
3Y Avg
10.47%
5Y Avg
9.16%
Market Cap
$1.71B
Operating Cash Flow Yield
N/A
TTM Avg
0.81%
3Y Avg
0.81%
5Y Avg
0.81%
Market Cap
$1.73B
Operating Cash Flow Yield
N/A
TTM Avg
9.83%
3Y Avg
9.83%
5Y Avg
9.83%
Market Cap
$1.74B
Operating Cash Flow Yield
11.84%
TTM Avg
5.31%
3Y Avg
4.07%
5Y Avg
4.23%
Market Cap
$1.74B
Operating Cash Flow Yield
3.26%
TTM Avg
2.57%
3Y Avg
2.57%
5Y Avg
2.57%
Market Cap
$1.74B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Operating Cash Flow Yield
0.09%
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
0.72%
Market Cap
$1.75B
Operating Cash Flow Yield
14.71%
TTM Avg
14.28%
3Y Avg
10.20%
5Y Avg
7.72%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.70B | N/A | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 18.69% | 11.27% | 10.47% | 9.16% |
| Personalis, Inc. (PSNL)vs › | $1.71B | N/A | 0.81% | 0.81% | 0.81% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | N/A | 9.83% | 9.83% | 9.83% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 11.84% | 5.31% | 4.07% | 4.23% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | 3.26% | 2.57% | 2.57% | 2.57% |
| Absci Corporation (ABSI)vs › | $1.74B | N/A | N/A | N/A | N/A |
| Novocure Ltd (NVCR)vs › | $1.74B | 0.09% | 0.08% | 0.08% | 0.72% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | 14.71% | 14.28% | 10.20% | 7.72% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
